Recurring mandate

MoCRA US Agent and facility registration services.

Facility registration, annual product listing and a US Agent for foreign facilities, with biennial renewals handled for you.

Biennial renewals: check your date
US retail beauty aisle, market banner

What is a MoCRA US Agent?

A US Agent is the person or entity a foreign cosmetic facility designates to act as its point of contact with the FDA in the United States. The requirement comes from MoCRA — the Modernization of Cosmetics Regulation Act — which extended FDA oversight of cosmetics and created obligations that did not previously exist for foreign manufacturers. The agent is not a distributor, not a consultant on retainer, and not a mailbox. It is a named, reachable US presence that the FDA can contact directly.

For a foreign facility, the practical effect is simple. Without a designated US Agent, the facility cannot complete its MoCRA registration. The agent’s details are part of the registration record, and the FDA uses them as the channel for correspondence, questions, and any follow-up on the facility’s filings. If the FDA cannot reach a US contact, the facility has no one to receive the message.

The US Agent is the FDA's point of contact in the United States

The agent receives FDA communications on behalf of the foreign facility and relays them onward. That includes routine correspondence and any request for information tied to registration or listing. The agent must be physically located in the United States and reachable during US business hours — the role exists precisely because the FDA needs a domestic party to contact.

This is the function that defines the role. Everything else the agent does flows from being the reachable US endpoint for a foreign facility’s regulatory correspondence.

Who must designate a US Agent

Foreign facilities that manufacture or process cosmetic products for US distribution must designate a US Agent. The obligation attaches to the facility, not to the brand name on the label, and it applies whether the facility is a contract manufacturer, a fill-and-finish operation, or a brand’s own overseas production site.

If your product is made outside the United States and sold into the US market, the facility that made it needs a US Agent. CIGREG acts as that agent for foreign cosmetic facilities, and holds the designation so the facility can register and stay reachable.

US Agent vs. Responsible Person

The Responsible Person and the US Agent are distinct roles under MoCRA, and conflating them is one of the most common errors in US market entry. The Responsible Person owns product-level obligations — safety substantiation, adverse event records, labelling. The US Agent owns the communication channel between the foreign facility and the FDA.

A single organisation can hold both roles, and CIGREG does. But the obligations do not merge. A brand that appoints a US Agent has not thereby appointed a Responsible Person, and vice versa. Both must be in place, and both must be named.

What the law requires

Federal registration, listing and a US Agent.

MoCRA requires

Deadlines and who does what

The dates that matter, and the split most brands miss.

MoCRA’s registration and listing deadlines have already passed for products marketed at the effective date. If you sell in the US now and have not filed, you are non-compliant now, not still inside a grace period.

Reviewed by Cassandra Maddocks, chemist & biochemist · last reviewed 26 July 2026

Foreign cosmetic facilities selling into the US must register with the FDA, name a US Agent, and keep a product listing current under MoCRA. CIGREG acts as your named US Agent, files registrations and listings in SPL through Cosmetics Direct, and tracks your biennial renewal date.

Legal basis: FDA: MoCRA, FDA Cosmetics Direct.

Key dates

How CIGREG covers it

What is included.

A mandate that registers your facilities, maintains your listing, acts as your US Agent and keeps your renewals on track.

There is no FDA fee to register a facility or list a product under section 607 of the FD&C Act. The cost is in preparing the submissions correctly and keeping them current, which is what our fixed setup fee covers. Cosmetics Direct is the FDA’s free SPL authoring tool; the required XML format is where first-time filers most often get stuck, so we handle the formatting for you rather than leave you with the portal.

What we need from you

The inputs that let us file.

Registration and listing move quickly once we have the facts. Most of what we need already exists in your production and label records. What the listing duty involves, and why it belongs to the Responsible Person rather than the factory, is explained in our product listing guide. The product listing has to name the products you market and their ingredients, so an accurate ingredient list per product is the piece we cannot proceed without.

If you already hold an FDA Establishment Identifier for a facility, we use it. If you do not, we obtain it as part of the work. Where you sell through a contract manufacturer, we confirm which party is registering the facility and which is doing the product listing, so the two filings line up.

To register and list, we ask for

Edge cases and scope

Where MoCRA gets more specific.

A few situations change what applies to you. We flag these at the start so the scope is right before anything is filed.

How it fits the other markets

US coverage alongside the EU, UK and Switzerland.

The US regime is separate from the EU, UK and Swiss ones, and a US filing does nothing for the others. A brand selling across all four markets needs an EU Responsible Person with CPNP notification under Reg. 1223/2009, a UK Responsible Person with SCPN notification through OPSS, a responsible person with a Swiss address, and MoCRA registration with a US Agent. These are four legal regimes, four sets of obligations, and portals that do not talk to each other.

We hold all four in one relationship. The same team that runs your US MoCRA mandate handles your EU, UK and Swiss obligations, so renewal dates across every market are tracked in one place instead of scattered across separate vendors. Where a product is going to more than one market, we reuse the same ingredient and label data rather than asking for it four times.

The four regimes

Who it is for

Brands selling cosmetics into the United States.

If your cosmetics are manufactured or processed at a facility selling into the US, and particularly at a facility outside the United States, MoCRA requires facility registration, an annual product listing and, for foreign facilities, a designated US Agent. This mandate suits brands that want US coverage handled correctly, with renewal dates tracked for them. It fits indie and direct-to-consumer brands that have deferred MoCRA and need to catch up, and portfolio accounts running several facilities with staggered renewal dates.

Why brands choose CIGREG for this

Pricing

Fixed, transparent pricing.

MoCRA facility registration and product listing setup is a fixed fee. Ongoing monitoring and renewals are covered under Compliance Care.

Prices in USD.

See full pricing →

FAQ

Common questions.

Yes. Under MoCRA, foreign facilities that manufacture or process cosmetic products for US distribution must designate a US Agent located in the United States. CIGREG holds that designation on behalf of foreign facilities so the registration record is complete and the FDA has a reachable US contact.

The agent acts as the FDA's point of contact in the United States for the foreign facility, receiving and relaying regulatory communications. CIGREG handles that correspondence and keeps the facility informed of anything the FDA raises. The role is a communication channel, not a substitute for the facility's own compliance obligations.

No. The Responsible Person and the US Agent are distinct roles under MoCRA, covering product-level obligations and FDA communication respectively. CIGREG can hold both, but they remain separate designations. A brand needs both in place, not one standing in for the other.

No — they are separate obligations. Facility registration covers the establishment that manufactures or processes the product; product listing covers the individual products placed on the US market. CIGREG supports both, and the US Agent designation sits alongside them rather than replacing either.

Yes. CIGREG acts as the official Responsible Person across the EU, UK and Switzerland and as US Agent under MoCRA, so a brand can consolidate all four jurisdictions with one provider. That removes the need to coordinate separate agents in each market. The US Agent designation is filed independently of any EU or UK appointment.

Related

Pairs well with.

Need to be MoCRA-ready?

MoCRA renewals run on your facility’s own two-year cycle. Tell us your facilities and products and we will quote your US coverage at a fixed price.

In practice

Compliance, in the real world.

US agent desk handling FDA filingsA facility-registration confirmationUS retail beauty products